Previous Close | 0.0500 |
Open | 0.3000 |
Bid | 0.0000 |
Ask | 0.7500 |
Strike | 17.50 |
Expire Date | 2024-05-17 |
Day's Range | 0.0500 - 0.3000 |
Contract Range | N/A |
Volume | |
Open Interest | 11 |
Healthy transplanted human glial cells replaced diseased glial cells in the brains of human glial chimeric Huntingtin mice Additional proof-of-concept for the advancement of SC379, Sana’s pluripotent stem cell-derived glial progenitor cell product candidate SEATTLE, May 21, 2024 (GLOBE NEWSWIRE) -- Sana Biotechnology, Inc. (NASDAQ: SANA), a company focused on changing the possible for patients through engineered cells, today highlighted that Nature Biotechnology has published a paper titled “You
There's no doubt that money can be made by owning shares of unprofitable businesses. For example, although Amazon.com...
Aligns with Analyst Projections Amidst Strategic Clinical Advancements